This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. A diverse array of neurons is essential for mammalian nervous system function. It is well known that the loss or dysfunction of specific subsets of neurons causes distinct neurological disorders. Parkinson's disease which has a devastating and negative impact on human health is the result of the degeneration of midbrain dopamine neurons of the substantia nigra, which are positioned in the lateral midbrain. The loss of substantia nigra dopamine neurons results in the inability to properly control movement. A current line of treatment proposed to treat Parkinson's disease is to use embryonic stem cell or induced pluripotent stem cell based therapy. The fundamental concept using cell based therapies is to transplant dopamine neuron precursors into patients with Parkinson's disease. A surrogate to test these approaches is transplant dopamine neuron precursors into animal models with midbrain dopamine neuron loss. However, a significant knowledge gap is that we do not understand how substantia nigra neurons are established during mammalian development, which translates into a problem of how to make the appropriate type of dopamine neuron. These deficits need to be addressed to design effective cell-based therapies to treat neurodegenerative diseases like Parkinson's disease. Currently there is no protocol to effectively instruct stem cells to acquire the most appropriate fate to ameliorate MbDA neuron-specific diseases. We have identified the dopamine neuron progenitor pool in vivo and determined that these progenitors express the gene Wnt1 during multiple critical steps for dopamine neuron development. The purpose of this proposal is to establish the molecular identity of Wnt1-expressing progenitors that contribute to developing dopamine neurons and to identify how WNT signaling specifies MbDA neuron progenitors. The studies in this proposal forge a link between the concept of cell fate specification and the problem of how distinct neuronal subtypes are established. An expected outcome is that we will elucidate regulatory components used to control the development of MbDA neuron subtypes from a complex progenitor pool. The positive impact of this application is that by uncovering how subtypes are allocated, we will provide a molecular scaffold that can be exploited to effectively guide stem cells to acquire a unique MbDA identity.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR025179-03
Application #
8360135
Study Section
Special Emphasis Panel (ZRR1-RI-2 (01))
Project Start
2011-07-01
Project End
2012-06-30
Budget Start
2011-07-01
Budget End
2012-06-30
Support Year
3
Fiscal Year
2011
Total Cost
$265,181
Indirect Cost
Name
Rhode Island Hospital
Department
Type
DUNS #
075710996
City
Providence
State
RI
Country
United States
Zip Code
02903
Li, Ming; Tucker, Lynne D; Asara, John M et al. (2016) Stem-loop binding protein is a multifaceted cellular regulator of HIV-1 replication. J Clin Invest 126:3117-29
Yang, Wentian; Wang, Jianguo; Moore, Douglas C et al. (2013) Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling. Nature 499:491-5
Tang, Xiaoli; Wen, Sicheng; Zheng, Dong et al. (2013) Acetylation of drosha on the N-terminus inhibits its degradation by ubiquitination. PLoS One 8:e72503
Li, Ming; Aliotta, Jason M; Asara, John M et al. (2012) Quantitative proteomic analysis of exosomes from HIV-1-infected lymphocytic cells. Proteomics 12:2203-11
Liu, Liansheng; Papa, Elaine F; Dooner, Mark S et al. (2012) Homing and long-term engraftment of long- and short-term renewal hematopoietic stem cells. PLoS One 7:e31300
Aliotta, Jason M; Lee, David; Puente, Napoleon et al. (2012) Progenitor/stem cell fate determination: interactive dynamics of cell cycle and microvesicles. Stem Cells Dev 21:1627-38
Ellisor, Debra; Rieser, Caroline; Voelcker, Bettina et al. (2012) Genetic dissection of midbrain dopamine neuron development in vivo. Dev Biol 372:249-62
Chan, Gordon; Cheung, Laurene S; Yang, Wentian et al. (2011) Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells. Blood 117:4253-61
Del Tatto, Michael; Ng, Thomas; Aliotta, Jason M et al. (2011) Marrow cell genetic phenotype change induced by human lung cancer cells. Exp Hematol 39:1072-80
Li, Ming; Patton, Dorothy L; Cosgrove-Sweeney, Yvonne et al. (2011) Incorporation of the HIV-1 microbicide cyanovirin-N in a food product. J Acquir Immune Defic Syndr 58:379-84

Showing the most recent 10 out of 23 publications